Pediatrix Medical Group (MD) Competitors $11.98 -0.27 (-2.20%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$11.98 -0.01 (-0.04%) As of 08/1/2025 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, BTSG, and SHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), BrightSpring Health Services (BTSG), and Sotera Health (SHC). Pediatrix Medical Group vs. Its Competitors Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed CorVel BrightSpring Health Services Sotera Health Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Do analysts recommend MD or AMED? Pediatrix Medical Group presently has a consensus target price of $16.67, suggesting a potential upside of 39.12%. Amedisys has a consensus target price of $100.50, suggesting a potential upside of 2.02%. Given Pediatrix Medical Group's higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Amedisys 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media prefer MD or AMED? In the previous week, Amedisys had 19 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 22 mentions for Amedisys and 3 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.12 beat Amedisys' score of 1.06 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amedisys 8 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, MD or AMED? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.51-$99.07M-$1.01-11.86Amedisys$2.35B1.38$43.23M$2.5738.33 Is MD or AMED more profitable? Amedisys has a net margin of 3.56% compared to Pediatrix Medical Group's net margin of -4.17%. Pediatrix Medical Group's return on equity of 17.43% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group-4.17% 17.43% 6.35% Amedisys 3.56%12.91%7.29% Which has more volatility and risk, MD or AMED? Pediatrix Medical Group has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Do insiders & institutionals hold more shares of MD or AMED? 97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 94.4% of Amedisys shares are held by institutional investors. 0.9% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 2.1% of Amedisys shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAmedisys beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.03B$7.13B$5.53B$20.47BDividend YieldN/A2.89%4.74%3.71%P/E Ratio-11.8615.6119.2826.72Price / Sales0.5134.05440.8757.15Price / Cash6.7925.3535.0722.46Price / Book1.348.618.254.43Net Income-$99.07M$239.96M$3.25B$993.74M7 Day Performance-4.66%-5.48%-3.73%-3.39%1 Month Performance-12.94%-3.73%4.28%-2.10%1 Year Performance49.94%18.27%25.85%10.09% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.8869 of 5 stars$11.98-2.2%$16.67+39.1%+45.1%$1.03B$2.01B-11.864,305Positive NewsUpcoming EarningsAMEDAmedisys2.9214 of 5 stars$96.91-1.1%$100.67+3.9%+0.4%$3.21B$2.35B35.7619,000Trending NewsEarnings ReportAnalyst RevisionAMNAMN Healthcare Services4.4903 of 5 stars$19.71-0.5%$32.08+62.8%-73.3%$758.03M$2.98B-4.552,968Positive NewsUpcoming EarningsCCRNCross Country Healthcare3.5842 of 5 stars$13.81+1.5%$17.93+29.8%-25.7%$445.85M$1.34B-26.068,205News CoverageLHLabcorp4.9013 of 5 stars$261.15-1.4%$285.00+9.1%+12.0%$22.18B$13.01B28.8270,000Insider TradeDGXQuest Diagnostics4.9403 of 5 stars$167.84-0.4%$186.00+10.8%+15.7%$18.85B$9.87B20.1056,000Positive NewsAnalyst UpgradeInsider TradeDVADaVita4.4393 of 5 stars$145.37+0.1%$167.40+15.2%+0.7%$10.96B$12.82B14.4176,000News CoveragePositive NewsUpcoming EarningsCHEChemed4.9713 of 5 stars$464.55-1.3%$596.67+28.4%-29.0%$6.89B$2.43B22.6315,695Trending NewsEarnings ReportAnalyst ForecastCRVLCorVel1.2647 of 5 stars$88.07-0.8%N/A-15.2%$4.56B$895.59M47.955,075News CoverageUpcoming EarningsBTSGBrightSpring Health Services2.9121 of 5 stars$20.48-0.2%$24.90+21.6%+60.6%$3.61B$11.27B73.1435,000Trending NewsEarnings ReportGap DownSHCSotera Health2.444 of 5 stars$12.29-0.1%$16.00+30.2%-18.2%$3.49B$1.10B153.643,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors BTSG Competitors SHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
